Laborie Medical Technologies has acquired the JADA® System for $465 million, emphasizing the urgent need for innovation in maternal health solutions.

Target Information

Laborie Medical Technologies has announced its acquisition of the JADA® System for $465 million, a significant transaction that highlights an urgent need for innovation in maternal health. The JADA System offers a rapid, FDA-cleared solution for managing abnormal postpartum bleeding, a condition that is a leading cause of maternal mortality worldwide, especially in low-resource environments and marginalized communities.

Designed to provide frontline clinicians with reliable tools for managing acute gestational emergencies, the JADA System aims to bridge the critical gaps in postpartum care. Currently utilized in thousands of hospitals across over 20 countries, this technology embodies a global need for effective maternal healthcare solutions.

Industry Overview

The maternal healthcare sector faces significant challenges, characterized by stark disparities both in the United States and globally. Issues such as postpartum hemorrhage not only affect the wellbeing of mothers but also bri